Ocugen, Inc
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ocugen, Inc and other ETFs, options, and stocks.About OCGN
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN.
OCGN Key Statistics
Stock Snapshot
As of today, Ocugen, Inc(OCGN) shares are valued at $2.04. The company's market cap stands at 667.27M, with a P/E ratio of -9.04.
On 2026-03-22, Ocugen, Inc(OCGN) stock moved within a range of $2.00 to $2.30. With shares now at $2.04, the stock is trading +2.0% above its intraday low and -11.3% below the session's peak.
Trading volume for Ocugen, Inc(OCGN) stock has reached 25.07M, versus its average volume of 15.78M.
Over the past 52 weeks, Ocugen, Inc(OCGN) stock has traded between a high of $2.73 and a low of $0.56.
Over the past 52 weeks, Ocugen, Inc(OCGN) stock has traded between a high of $2.73 and a low of $0.56.
OCGN News
Ocugen OCGN is building its ocular portfolio around a modifier gene therapy idea: instead of designing a therapy for a single genetic defect, the platform is in...
Ocugen OCGN is pushing three retinal gene therapy programs toward late-stage milestones, with multiple data readouts and regulatory steps clustered into 2026 an...
Analyst ratings
100%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.